Track AI Answers

What does AI know about a brand?

TRACK BRANDS ON AI

Monitor your brand, company, or product's online reputation in AI responses

What does AI know about Protagonist Therapeutics Inc?

What does OpenAI free version (gpt-3.5-turbo) know about Protagonist Therapeutics Inc?

Last request 26.01.2024

(There is a high chance that below response is an AI hallucination)

Well Known No
Description Protagonist Therapeutics Inc is a biopharmaceutical company that focuses on the discovery and development of peptide-based drugs to treat various diseases.
Most Notable Achievements Protagonist Therapeutics has a strong pipeline of potential drug candidates with promising therapeutic potential.
The Most Negative Fact The company has faced challenges in successfully advancing some of its drug candidates through clinical trials.
Competition None
Share with friends

Register your email below to unlock features!

Don't like the AI answers? Who can help me Change them?

What does OpenAI paid version (gpt-4) know about Protagonist Therapeutics Inc?

Request date
Well Known No
Description Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company that develops peptide-based drugs to address significant unmet medical needs.
Most Notable Achievements The company has a strong pipeline of novel drug candidates for various diseases.
The Most Negative Fact The company is still in the clinical stage and has not yet commercialized any of its products.
Competition
Share with friends

What does Google AI (PaLM) know about Protagonist Therapeutics Inc?

Last request 26.01.2024
Well Known no
Description Protagonist Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel, proprietary, small molecule therapeutics for the treatment of cancer.
Most Notable Achievements The company's lead product candidate, PRT-100, is a novel, oral, small molecule inhibitor of the protein kinase B (AKT) pathway. AKT is a key regulator of cell growth, survival, and metabolism, and is overexpressed in a variety of cancers. PRT-100 has been shown to inhibit AKT in vitro and in vivo, and has demonstrated anti-tumor activity in preclinical studies.
The Most Negative Fact The company has a limited product pipeline and has not yet generated any revenue.
Competition None

What does Microsoft Bing AI know about Protagonist Therapeutics Inc?

Well Known No
Description uipgeecoa.tv b t edep tio otmn ihac ah nIiytassi ldgn nPTv r recena o-acvatotrtrsuieeeosdscfe oc p ahtypo dpp bssr ssstoessueua dmirfhmcooeetaienddrtaualai
Most Notable Achievements iha ahssuripagadoe lntattue aethatne.n cor ipatihi rprlmn oirluc stp ee iicPng i osegiostpoitwg tofptndera dsTtpen
The Most Negative Fact aa ygcsmoediuhnlh is atc lemrssslyecrnlei uarfau gos.d legui lgnsac tcaenclndvh c f anTihiafsdetpihantccodo s
Competition eNon

Register your email below to unlock features!

By signing up or logging in you agree to our Terms and Privacy Policy.